Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracameral Levofloxacin vs Cefazolin in Cataract Surgery
NCT06710977Phase 1Completed
- Sponsor
- Tan Tock Seng Hospital
- Start
- Jan 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of levofloxacin in endophthalmitis (2 arms), sponsored by Tan Tock Seng Hospital. Primary endpoint: Occurrence of Endophthalmitis at 3 months. Started Jan 2022; status: completed.
02
Drugs
levofloxacin
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NCT06710977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06710977.